This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB01641/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01641/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01641/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01641/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01641
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB01641 n10:DB01641
dcterms:title
(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One
adms:identifier
n8:DB01641 n9:5ZA n12:46936180 n13:46505368
n3:IUPAC-Name
n4:271B5F61-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5F67-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5F66-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5F63-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5F64-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5F65-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5F5F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5F60-363D-11E5-9242-09173F13E4C5 n4:271B5F5D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5F5E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5F6D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5F6E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5F68-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5F69-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5F6B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5F6A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5F6C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5F73-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5F75-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5F76-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5F72-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5F71-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5F74-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5F62-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5F6F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5F70-363D-11E5-9242-09173F13E4C5